LabGenius raises 35 million euros to target cancer with smarter antibodies
Sifted - 21-May-2024Leveraging robotics and machine learning to design precise cancer treatments with minimal side effects
Join the club for FREE to access the whole archive and other member benefits.
Magazine that aims to provide the most comprehensive coverage of Europe's startup world
At Sifted we will make the case for the importance of European tech startups, and the value of a differentiated European approach that charts a course between the techno-libertarianism of California and the digital authoritarianism of China.
The energy, ideas, and ambition on display all across Europe deserve to be heard around the world. Our aim is to be the voice of this community of European startup entrepreneurs.
At Sifted, we’re for leaders, for pioneers and technologists. We’re also for anyone interested in cutting-edge innovation across Europe.
That’s why we’re deep-diving into Europe’s pools of research and expertise to explore and surface companies in emerging areas of technology which don’t always get the profile they deserve. From blockchain to biotech, fintech to factories of the future, we are inspecting these topics from new angles and uncovering innovation wherever there’s a spark.
Visit website: https://sifted.eu/
Details last updated 01-Sep-2019
Leveraging robotics and machine learning to design precise cancer treatments with minimal side effects
Planning to test its therapies in dogs next year, with human treatments expected in the near future
In future: no keys, no wallet, just an implant under the skin
Good to have another cyronics provider in Europe
There's a chance for at least one of these novel approaches might work